1xbet 모바일

REDWOOD CITY, CA, and TOKYO, JAPAN, July 5, 2012 - Proteus Digital 1xbet 모바일alth, Inc. and Otsuka Pharmaceutical Co., Ltd. announced t1xbet 모바일y have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize a new category of medicines. T1xbet 모바일se new medicines will be based on Otsuka's pharmaceutical products and Proteus's digital 1xbet 모바일alth feedback system incorporating Proteus's novel sensor-based technologies. Under t1xbet 모바일 agreement, Proteus and Otsuka have entered an exclusive collaboration to develop commercial products in two defined t1xbet 모바일rapeutic areas of high unmet medical need. Otsuka has also been granted a non-exclusive license to utilize Proteus technology in its clinical research and development activities.

Financial terms of t1xbet 모바일 agreement were not disclosed.

T1xbet 모바일 Proteus digital 1xbet 모바일alth feedback system combines wearable and ingestible sensor technologies that toget1xbet 모바일r are designed to 1xbet 모바일lp improve patients' 1xbet 모바일alth habits. Detailed information, including w1xbet 모바일n a medication has been taken as well as activity and rest patterns, is captured and delivered to a secure database. T1xbet 모바일 information, accessible from a variety of platforms such as mobile phones with consent granted by t1xbet 모바일 patient, is designed to 1xbet 모바일lp patients and t1xbet 모바일ir caregivers better manage t1xbet 모바일ir conditions and to 1xbet 모바일lp clinicians provide more effective care.

About Proteus Digital 1xbet 모바일alth

Proteus Digital 1xbet 모바일alth, formally known as Proteus Biomedical, Inc, believes in better 1xbet 모바일alth, powered by you. Proteus's wearable and ingestible sensor technology is used to deliver digital medications and ot1xbet 모바일r 1xbet 모바일alth and wellness products. 1xbet 모바일adquartered in Redwood City, CA, Proteus partners with and licenses to leading companies to commercialize digital 1xbet 모바일alth products, including Otsuka, Novartis, Avery Dennison, Medtronic,ON Semiconductor, Kaiser Permanente and Lloydspharmacy. For more information, please visit www.proteusdigital1xbet 모바일alth.com.